Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03357341 · ClinicalTrials.gov registry record
Sensor and Electronic Health Records (EHR) Integration Pilot Study
A clinical trial, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- 194
- Enrollment target
NCT03357341 is a clinical trial that has completed, run by GlaxoSmithKline. The registered enrollment target is 194 participants.
The verdict
NCT03357341 has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- 194 participants
- Enrollment target
Study Summary
This is a pilot study that will evaluate the feasibility of collecting increasing amounts of clinical study data from subjects through sensor and web/app based methods and integrating it with data from their EHR to facilitate more efficient and meaningful research with acceptable quality. Approximately 100 subjects with asthma and 100 subjects with chronic obstructive pulmonary disease (COPD) will be enrolled in this prospective study. The subjects will be identified through integrated EHR records following which eligible subjects will receive study devices and training on proper use of the devices at Baseline visit. Data will be collected remotely from subject reports, devices and sensors over six months.
Interventions
- DRUG Salbutamol
- DEVICE Activity monitor
- DEVICE Mobile spirometer
- DEVICE Device sensor
- OTHER electronic diary card
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 194 participants |
| Start Date | 2018-07-23 |
| Est. Completion | 2019-09-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03357341
The ClinicalTrials.gov registry entry for NCT03357341 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Salbutamol is the first listed.
NCT03357341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03357341 about?
NCT03357341 is a clinical study titled "Sensor and Electronic Health Records (EHR) Integration Pilot Study". This is a pilot study that will evaluate the feasibility of collecting increasing amounts of clinical study data from subjects through sensor and web/app based methods and integrating it with data from their EHR to facilitate more efficient and meaningful research with acceptable quality. Approximat...
What is the current status of trial NCT03357341?
This trial is currently completed. The enrollment target is 194 participants. The study started on 2018-07-23. Estimated completion is 2019-09-27.
What interventions are being tested in trial NCT03357341?
The interventions under investigation include: Salbutamol (DRUG), Activity monitor (DEVICE), Mobile spirometer (DEVICE), Device sensor (DEVICE), electronic diary card (OTHER).
Who is sponsoring clinical trial NCT03357341?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.